Preclinical data reproducibility for R&D—the challenge for neuroscience
详细信息 查看全文
- 作者：Thomas Steckler
- 刊名：Psychopharmacology
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：232
- 期：2
- 页码：317-320
- 全文大小：129 KB
- 参考文献：1. Anderson DC, Kodukula K (2014) Biomarkers in pharmacology and drug discovery. Biochem Pharmacol 87:172-88 CrossRef
2. Begley CG, Ellis LM (2012) Drug development: raise standards for preclinical cancer research. Nature 483:531-33 CrossRef
3. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, Munafo MR (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365-76 CrossRef
4. Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374:86-9 CrossRef
5. Cyranoski D (2013) China drugs head fired over article row. Nature 498:283 CrossRef
6. Fang FC, Steen RG, Casadevall A (2012) Misconduct accounts for the majority of retracted publications. Proc Natl Acad Sci USA 109:17028-7033
7. Fanelli D (2009) How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 4:e5738 CrossRef
8. Fitz NF, Cronican AA, Lefterov I, Koldamova R (2013) Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models- Science 340:924 CrossRef
9. Franco A, Malhotra N, Simonovits G (2014) Publication bias in the social sciences: unlocking the file drawer. Science 345:1502-505 CrossRef
10. Frantz S (2004) Therapeutic area influences drug development costs. Nat Rev Drug Disc 3:466-67 CrossRef
11. Ioannidis JPA (2005) Why most published research findings are false. PLoS Med 2:e124 CrossRef
12. Ioannidis JPA (2014) How to make more published research true. PLoS Med 11:e1001747 CrossRef
13. Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, Fry D, Hutton J, Altman DG (2009) Survey of the quality of experimental design, statistical analysis and experimental reporting of research using animals. PLoS One 11:e7824 CrossRef
14. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Disc 3:711-15 CrossRef
15. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490:187-91 CrossRef
16. Lazzeroni LC, Lu Y, Belitskaya-Levy I (2014) P-values in genomics: apparent precision masks high uncertainty. Mol Psychiatry. doi:10.1038/mp.2013.184
17. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Khan AW, Glasziou P (2014) Biomedical research: increasing value, reducing waste. Lancet 383:101-04 CrossRef
18. McNutt M (2014) Journals unite for reproducibility. Science 346:678
19. Mehta J (2011) Preclinical Outsourcing Report: Long-term and more collaborative contracts to optimize cost structures. Contract Pha - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Pharmacology and Toxicology
Psychiatry - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-2072
文摘